Stay updated on Pro-Netupitant Palonosetron IV Safety Clinical Trial

Sign up to get notified when there's something new on the Pro-Netupitant Palonosetron IV Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pro-Netupitant Palonosetron IV Safety Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.1 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-02T00:23:01.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.1.
    Difference
    0.1%
    Check dated 2025-04-24T17:29:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding a clinical study on chemotherapy-induced nausea and vomiting, including detailed descriptions of the study's objectives, inclusion and exclusion criteria, and collaborator information. A new revision number has been added.
    Difference
    29%
    Check dated 2025-04-17T12:10:45.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-10T10:17:46.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:06:28.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:43:38.000Z thumbnail image

Stay in the know with updates to Pro-Netupitant Palonosetron IV Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pro-Netupitant Palonosetron IV Safety Clinical Trial page.